Home › NDC Lookup › RxCUI directory › RxCUI 197380

Atenolol 25 MG Oral Tablet — RxCUI 197380

RxNorm drug concept · Semantic clinical drug
RxCUI 197380 Semantic clinical drug · SCD ● Current RxNorm concept 72 FDA products 198 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197380
Official nameAtenolol 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped72
Package NDCs mapped198
Reported Medicaid activity (SDUD)765,683 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Atenolol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats high blood pressure and helps manage long-term angina. It is also used in people who are stable after a definite or suspected heart attack to lower the risk of death from...
  • Atenolol tablets are swallowed by mouth, usually once a day. Take it as your prescriber and the label direct. Your doctor may adjust the dose based on how you respond.
  • Please don't stop it suddenly. Stopping abruptly can make angina worse and has led to heart attacks and dangerous heart rhythms. Talk to your doctor first so they can guide you.
  • Tiredness, dizziness, cold hands and feet, and a slower heartbeat are the more common ones. Most are mild and pass. Call your doctor for fainting, wheezing, swelling, worsening bre...
📖 Read our full Atenolol guide →

🕸️ Concept Web — How Atenolol 25 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Atenolol 25 MG Oral Tablet RxCUI 197380

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Atenolol 1202
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tenormin 152413
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Atenolol Oral Tablet 370619
    • Atenolol Oral Product 1154378
    • Atenolol Pill 1154379
    • Atenolol Oral Tablet [Tenormin] 367659
    • Tenormin Oral Product 1182019
    • Tenormin Pill 1182020
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Atenolol 25 MG SCDC · 315437
  • Atenolol Oral Tablet SCDF · 370619
  • Atenolol Oral Product SCDG · 1154378
  • Atenolol Pill SCDG · 1154379

Brand-Name Concepts

  • Atenolol 25 MG Oral Tablet [Tenormin] SBD · 150750
  • Atenolol 25 MG [Tenormin] SBDC · 564787
  • Atenolol Oral Tablet [Tenormin] SBDF · 367659
  • Tenormin Oral Product SBDG · 1182019
  • Tenormin Pill SBDG · 1182020
  • Tenormin BN · 152413

📦 FDA Products & Package NDCs

72 products · 198 package NDCs
198 package NDCs map to RxCUI 197380 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-0752-01 100 TABLET in 1 BOTTLE (0093-0752-01) Atenolol Teva Pharmaceuticals USA, Inc. 1995-02-22
00093-0752-10 1000 TABLET in 1 BOTTLE (0093-0752-10) Atenolol Teva Pharmaceuticals USA, Inc. 1995-02-22
00093-0753-01 100 TABLET in 1 BOTTLE (0093-0753-01) Atenolol Teva Pharmaceuticals USA, Inc. 1995-02-17
00093-0753-05 500 TABLET in 1 BOTTLE (0093-0753-05) Atenolol Teva Pharmaceuticals USA, Inc. 2007-10-23
00093-0787-01 100 TABLET in 1 BOTTLE (0093-0787-01) Atenolol Teva Pharmaceuticals USA, Inc. 2004-11-16
00093-0787-10 1000 TABLET in 1 BOTTLE (0093-0787-10) Atenolol Teva Pharmaceuticals USA, Inc. 2004-11-16
00378-0218-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0218-01) Atenolol Mylan Pharmaceuticals Inc. 1999-06-17
00378-0218-10 1000 TABLET in 1 BOTTLE, PLASTIC (0378-0218-10) Atenolol Mylan Pharmaceuticals Inc. 1999-06-17
00378-0231-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0231-01) Atenolol Mylan Pharmaceuticals Inc. 1992-01-24
00378-0231-10 1000 TABLET in 1 BOTTLE, PLASTIC (0378-0231-10) Atenolol Mylan Pharmaceuticals Inc. 1992-01-24
00378-0757-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0757-01) Atenolol Mylan Pharmaceuticals Inc. 1992-01-24
00378-0757-10 1000 TABLET in 1 BOTTLE, PLASTIC (0378-0757-10) Atenolol Mylan Pharmaceuticals Inc. 1992-01-24
00615-8372-05 15 TABLET in 1 BLISTER PACK (0615-8372-05) Atenolol NCS HealthCare of KY, LLC dba Vangard Labs 2021-01-05
00615-8372-39 30 TABLET in 1 BLISTER PACK (0615-8372-39) Atenolol NCS HealthCare of KY, LLC dba Vangard Labs 2021-01-05
00615-8373-05 15 TABLET in 1 BLISTER PACK (0615-8373-05) Atenolol NCS HealthCare of KY, LLC dba Vangard Labs 2021-01-05
00615-8373-39 30 TABLET in 1 BLISTER PACK (0615-8373-39) Atenolol NCS HealthCare of KY, LLC dba Vangard Labs 2021-01-05
00904-7187-61 100 BLISTER PACK in 1 CARTON (0904-7187-61) / 1 TABLET in 1... Atenolol Major Pharmaceuticals 2007-10-31
24979-0244-07 90 TABLET in 1 BOTTLE (24979-244-07) TENORMIN Upsher-Smith Laboratories, LLC 2024-08-01
24979-0245-07 90 TABLET in 1 BOTTLE (24979-245-07) TENORMIN Upsher-Smith Laboratories, LLC 2024-08-01
24979-0246-07 90 TABLET in 1 BOTTLE (24979-246-07) TENORMIN Upsher-Smith Laboratories, LLC 2024-08-01
29300-0410-01 100 TABLET in 1 BOTTLE (29300-410-01) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0410-05 500 TABLET in 1 BOTTLE (29300-410-05) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0410-10 1000 TABLET in 1 BOTTLE (29300-410-10) Atenolol Unichem Pharmaceuticals (USA), Inc. 2022-08-26
29300-0411-01 100 TABLET in 1 BOTTLE (29300-411-01) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0411-05 500 TABLET in 1 BOTTLE (29300-411-05) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0411-10 1000 TABLET in 1 BOTTLE (29300-411-10) Atenolol Unichem Pharmaceuticals (USA), Inc. 2022-08-26
29300-0412-01 100 TABLET in 1 BOTTLE (29300-412-01) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0412-05 500 TABLET in 1 BOTTLE (29300-412-05) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0412-10 1000 TABLET in 1 BOTTLE (29300-412-10) Atenolol Unichem Pharmaceuticals (USA), Inc. 2022-08-26
43063-0805-01 100 TABLET in 1 BOTTLE, PLASTIC (43063-805-01) Atenolol PD-Rx Pharmaceuticals, Inc. 2017-12-01
43063-0805-30 30 TABLET in 1 BOTTLE, PLASTIC (43063-805-30) Atenolol PD-Rx Pharmaceuticals, Inc. 2017-11-28
43063-0805-90 90 TABLET in 1 BOTTLE, PLASTIC (43063-805-90) Atenolol PD-Rx Pharmaceuticals, Inc. 2017-12-13
43063-0952-30 30 TABLET in 1 BOTTLE, PLASTIC (43063-952-30) Atenolol PD-Rx Pharmaceuticals, Inc. 2020-10-18
43063-0952-90 90 TABLET in 1 BOTTLE, PLASTIC (43063-952-90) Atenolol PD-Rx Pharmaceuticals, Inc. 2019-02-28
50090-6241-00 30 TABLET in 1 BOTTLE (50090-6241-0) Atenolol A-S Medication Solutions 2022-11-23
50090-6241-02 100 TABLET in 1 BOTTLE (50090-6241-2) Atenolol A-S Medication Solutions 2022-11-23
50090-6241-05 90 TABLET in 1 BOTTLE (50090-6241-5) Atenolol A-S Medication Solutions 2022-11-23
50090-6935-00 90 TABLET in 1 BOTTLE (50090-6935-0) Atenolol A-S Medication Solutions 2023-12-14
50090-7603-00 90 TABLET in 1 BOTTLE (50090-7603-0) Atenolol A-S Medication Solutions 2025-07-15
51079-0684-20 100 BLISTER PACK in 1 CARTON (51079-684-20) / 1 TABLET in 1... Atenolol Mylan Institutional Inc. 1997-07-24
51079-0685-20 100 BLISTER PACK in 1 CARTON (51079-685-20) / 1 TABLET in 1... Atenolol Mylan Institutional Inc. 1997-07-23
51079-0759-20 100 BLISTER PACK in 1 CARTON (51079-759-20) / 1 TABLET in 1... Atenolol Mylan Institutional Inc. 1999-06-16
51655-0491-25 60 TABLET in 1 BOTTLE, PLASTIC (51655-491-25) Atenolol Northwind Health Company, LLC 2020-12-10
51655-0533-25 60 TABLET in 1 BOTTLE, PLASTIC (51655-533-25) Atenolol Northwind Health Company, LLC 2022-12-28
51655-0533-26 90 TABLET in 1 BOTTLE, PLASTIC (51655-533-26) Atenolol Northwind Health Company, LLC 2022-12-28
51655-0533-52 30 TABLET in 1 BOTTLE, PLASTIC (51655-533-52) Atenolol Northwind Health Company, LLC 2022-12-28
51655-0709-26 90 TABLET in 1 BOTTLE, PLASTIC (51655-709-26) Atenolol Northwind Health Company, LLC 2022-04-08
51655-0709-52 30 TABLET in 1 BOTTLE, PLASTIC (51655-709-52) Atenolol Northwind Health Company, LLC 2021-05-07
52427-0430-90 90 TABLET in 1 BOTTLE (52427-430-90) TENORMIN Almatica Pharma LLC 2015-04-15
52427-0431-90 90 TABLET in 1 BOTTLE (52427-431-90) TENORMIN Almatica Pharma LLC 2015-04-15
Observed labelers: Bryant Ranch Prepack (22) · Zydus Lifesciences Limited (15) · Zydus Pharmaceuticals USA Inc. (15) · ASCLEMED USA INC. (12) · Preferred Pharmaceuticals Inc. (12) · Aphena Pharma Solutions - Tennessee, LLC (10) · +24 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.